Literature DB >> 28239930

Secondary cutaneous peripheral T-cell lymphoma, unspecified, with generalized benign-looking dermatitis: a possibly distinct peripheral T-cell lymphoma.

Woo Jin Lee1, Hyun Ji Kang1, Chong Hyun Won1, Sung Eun Chang1, Jee Ho Choi1, Mi Woo Lee1.   

Abstract

BACKGROUND: Cutaneous lymphomas are a heterogeneous group of tumors with various clinical manifestations, histological features, and prognoses.
METHODS: Among 425 cases of cutaneous lymphoma, we describe eight cases of peripheral T-cell lymphoma, unspecified, presenting with generalized benign-looking dermatitis.
RESULTS: Our case series included eight cases of secondary cutaneous peripheral T-cell lymphoma, unspecified. The observed clinical morphology features included drug eruption-like generalized morbilliform maculopatches in two cases, generalized folliculitis-like papules in two cases, and generalized eczematous dermatitis-like papules and patches in four cases. Histopathological examination demonstrated tumor cell infiltrates of mainly atypical, small-to-medium lymphoid cells that were perivascularly or periadnexally distributed throughout the dermis. Immunohistochemical staining results for CD2, CD3, CD4, and CD8 revealed that the tumor cells were T-cells.
CONCLUSION: This collection of cases and literature review emphasizes the need for clinical suspicion of peripheral T-cell lymphoma, unspecified, in the differential diagnosis of adult patients with refractory eczematous or benign-looking skin lesions.
© 2017 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28239930     DOI: 10.1111/ijd.13493

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  1 in total

1.  A Retrospective Clinicopathologic Study of Korean Patients with Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified at a Single Tertiary Center.

Authors:  Ji-Hye Park; YoungHwan Choi; Hyun Jeong Byun; Se Jin Oh; Jong Hee Lee; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.